Growth and development of primordial follicles through to ovulatory status is associated with marked proliferation, recruitment and differentiation of somatic cells and with changes in oocyte size and morphology, reflecting both nuclear and cytoplasmic maturation. Most follicles (> 99.9%) never reach ovulatory status, but undergo atresia at some point along this extended developmental pathway. The mechanisms that regulate the ordered recruitment of quiescent primordial follicles into the growing pool have not been determined, but are likely to involve locally produced growth and differentiation factors, some of which emanate from the oocyte itself, including growth and differentiation factor 9 (GDF-9) and bone morphogenetic protein 15 (BMP-15) (Elvin et al., 2000) . Follicle development up to the late preantral and early antral stages occurs independently of pituitary gonadotrophins despite the fact that FSH receptor mRNA transcripts are detectable in granulosa cells from as early as the primary follicle stage (Findlay and Drummond, 1999) . Experiments involving hypophysectomy, gonadotrophin suppression and selective replacement therapy have shown that gonadotrophic support is obligatory for the continued growth of follicles beyond the small-medium antral stage. Transient increases in FSH secretion during the ovarian cycle are responsible for initiating recurrent waves of antral follicle development (approximately 10-20 follicles per wave or cohort). By a mechanism that has yet to be fully resolved, but which probably involves subtle differences in their responsiveness to FSH and LH, one (or several, depending on species) of these follicles is selected for continued growth to ovulatory size (referred to as the 'dominant follicle'), whereas the other 'subordinate follicles' cease growing and are destined for atresia.
Locally produced growth factors in the ovary
In addition to extrinsic regulation by pituitary gonadotrophins and metabolic hormones, evidence has emerged to support the involvement of various locally produced growth factors as co-regulators of folliculogenesis (Fig. 1) . The list of factors implicated so far includes insulin-like growth factors (IGFs),
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The changing pattern of granulosa cell expression of inhibin/activin subunits and follistatin during follicle development and their differential regulation by extrinsic and intraovarian factors supports evidence from functional studies, mostly in vitro, that these proteins have important roles in folliculogenesis, oocyte maturation and corpus luteum function. Gonadal inhibins function as negative feedback hormones to regulate the synthesis and secretion of pituitary FSH, a key determinant of follicle development, but there is little supportive evidence for a peripheral endocrine role for ovary-derived activins or follistatin in this regard. However, activins and follistatin are expressed in numerous other tissues, including anterior pituitary, and they are firmly implicated as local intrapituitary regulators of FSH secretion. Intraovarian actions of granulosa cell-derived activins include the promotion of granulosa cell proliferation and upregulation of FSH receptors, P450arom, oestrogen synthesis, granulosa cell LH receptors and enhancement of oocyte maturation. Through its activin-binding role, follistatin can reverse each of these activin-induced responses. In addition to their endocrine feedback role, granulosaderived inhibins can sensitize theca cells to LH, thereby enhancing the production of androgens, an essential requirement for follicular oestrogen synthesis. Activins can oppose this effect and suppress thecal androgen production. Granulosa cells overproduce inhibin α subunit precursor relative to βA/βB subunit precursors and evidence indicates that different parts of the inhibin α subunit precursor have intrinsic biological activities distinct from inhibin αβA/B dimer, and serve as additional local modulators of follicle and corpus luteum function.
IGF-binding proteins (IGFBPs), epidermal growth factor (EGF), transforming growth factor α (TGF-α), fibroblast growth factor (FGF), transforming growth factor β (TGF-β), GDF-9, BMP-15, inhibins, activins and follistatins (Webb et al., 1999; Elvin et al., 2000) . This article will focus on the last three factors only. It should be pointed out that intraovarian expression of a particular growth factor, or its receptor, may itself be gonadotrophin-dependent, in which case it may be considered to serve as a local mediator of gonadotrophin action. Alternatively, a growth factor may exert a regulatory action by modulating cellular responsiveness to gonadotrophins (for example by upregulating FSH receptors). For instance, a growth factor that augments FSH responsiveness would promote further follicle growth, whereas one that attenuates FSH responsiveness might precipitate atresia.
As emphasized by Findlay (1993) , a number of issues should be addressed before a substance can be classed as having an autocrine or paracrine role: (i) whether local production of the factor can be demonstrated (for example expression of its mRNA, immunochemical localization within cells or net synthesis in vivo or in vitro); (ii) whether its production is modulated by other factors (for example systemic signals or other locally produced factors); (iii) whether specific receptors are present and whether the factor elicits a demonstrable cellular response, either on the same type of cell that secreted it (autocrine action) or on neighbouring cells (paracrine action); (iv) whether the action of the factor is regulated locally (for example by a binding protein, formation from a pro-hormone, enzymatic degradation or cellular uptake); (v) whether evidence obtained in vivo is consistent with the proposed local autocrine-paracrine action of the factor shown in vitro.
These points are worth keeping in mind when considering the evidence supporting intraovarian roles of inhibins, activins and follistatin. Apart from the final and possibly most challenging point, that relating to confirmation of findings in vitro in 'whole animal' models, these conditions have largely been met.
Inhibins, activins and follistatins

Basic features
Inhibins and activins are disulphide-linked dimeric glycoproteins belonging to the TGF-β superfamily. Inhibins are dimers of a unique α subunit linked to either a βA or βB subunit to generate inhibin A (α-βA) or inhibin B (β-βB) (Fig. 2) . Dimerization of β subunits alone gives rise to three forms of activin referred to as activin A (βA-βA), activin AB (βA-βB) and activin B (βB-βB). The α, βA and βB subunits are derived from three different precursor polypeptides encoded by distinct genes (Ying, 1988) . Differential posttranslational processing, particularly of the α precursor, gives rise to several different size variants of inhibin A and B. Follistatin, a cysteine-rich monomeric glycoprotein encoded by a single gene, is structurally unrelated to the TGF-β superfamily, but is linked functionally through its role as a high-affinity binding protein for activins. There are several different isoforms of follistatin due to alternative mRNA splicing and post-translational modification.
Inhibins, activins and follistatins were first identified in ovarian follicular fluid through their ability to modulate the secretion of FSH from pituitary gonadotrophs in vitro: inhibins and follistatin suppress FSH secretion, whereas activins enhance FSH secretion. Although a long-loop negative feedback role for ovarian inhibins in the regulation of FSH secretion is now well established in both sexes (Knight, 1996; Mather et al., 1997; de Kretser et al., 2000) , it is unlikely that activins of ovarian origin exert endocrine effects on the pituitary. Rather, activins are produced by, and subserve local regulatory roles in, a diverse range of tissues including the anterior pituitary (Besecke et al., 1997) . Moreover, it appears that all of the activin present in the peripheral circulation is tightly bound to follistatin, which effectively neutralizes its biological activity and prevents it from acting on distant target tissues (Woodruff, 1998) . Follistatin also binds to inhibin, but with much lower affinity, and this binding does not appear to neutralize inhibin bioactivity.
Receptors
Activin receptors were cloned and characterized in the early 1990s (reviewed by Zimmerman and Mathews, 1996) . Both type I and II activin receptors are expressed by granulosa cells, theca cells and oocytes, consistent with local intraovarian actions on these types of cell (Eramaa et al., 1995; Mather et al., 1997; Sidis et al., 1998) . Inhibin-specific receptors have not yet been isolated or characterized, although recent progress has been made towards this goal (Woodruff, 1999) . It was recently discovered that inhibin binds (via its α subunit) with high affinity to the type III TGF-β receptor, betaglycan (Lewis et al., 2000) , and that this binding markedly enhances the binding of inhibin (via its β subunit) to the type II activin receptor. Therefore, at least some of the activin-opposing actions of inhibin probably involve interference with activin binding to its type II receptor, which prevents activin-induced heteromerization of type I and type II receptors, a requirement for triggering the activin-dependent intracellular signalling cascade (Lebrun et al., 1997) . A further possibility indicated by this recent discovery is that free inhibin α subunit could facilitate activin action by competing with inhibin for binding to betaglycan; this would reduce the interaction of inhibin with the type II activin receptor. In other words, free inhibin α subunit could function as an inhibin antagonist and a physiological agonist of activin. This hypothesis remains to be evaluated.
Intraovarian actions
Compelling evidence, mainly from studies in vitro on isolated follicles, granulosa cells, theca cells and oocytes supports the notion that activins, follistatin and, to a lesser degree, inhibins synthesized by follicular granulosa cells exert local autocrine-paracrine actions to modulate follicle growth, gonadotrophin responsiveness, steroidogenesis, oocyte maturation, ovulation and corpus luteum function (Fig. 3) . Studies in vivo involving transgenic 'knockout' mice deficient in inhibin/activin α or β subunits, activin receptors or follistatin (reviewed by Nishimori and Matzuk, 1996) have also provided vital clues about the critical roles of these proteins in ovarian function. This evidence will be considered in more detail in the following sections.
Autocrine-paracrine effects on granulosa cells
Studies in vitro support a local intrafollicular role of activin in promoting granulosa cell proliferation and differentiation. Activin-induced proliferation has been observed with cultured rat granulosa cells from both small and large follicles (Li et al., 1995; Miro and Hillier, 1996) and with human granulosa lutein cells (Rabinovici et al., 1990) . In addition, targeted deletion of the inhibin α subunit gene in mice, which leads to overproduction of activin, is associated with uncontrolled proliferation of granulosa cells and ovarian tumour development (Matzuk et al., 1992) . In contrast, in 'knockout' mice lacking activin type IIB receptors, follicle development was arrested at an early antral stage, consistent with a key role for activin in granulosa cell proliferation and differentiation (Nishimori and Matzuk, 1996) . However, it should be noted that plasma FSH concentrations were markedly suppressed in these activin receptor-deficient mice, making it difficult to distinguish between an indirect pituitary FSH-mediated and direct intraovarian action of activin receptor deletion. Acquisition of granulosa cell responsiveness to FSH is considered a pivotal event in the life history of a follicle. The discovery that activin can promote FSH receptor expression on undifferentiated rat granulosa cells (Hasegawa et al., 1988; Xiao et al., 1992 ) is particularly significant since this could explain how a follicle at the late preantral to early antral stage progresses from a gonadotrophin-independent to a gonadotrophin-dependent stage of development. Given the ability of follistatin to bind and neutralize activin, the proposed action of activin to promote FSH receptor expression in small follicles would operate most successfully in the absence of follistatin. Evidence that undifferentiated rat granulosa cells express relatively little follistatin in comparison with cells from more developmentally advanced follicles (Shimasaki et al., 1989; Nakatani et al., 1991) supports this concept. Moreover, indirect evidence from in situ hybridization studies on primate ovaries implies that follicles in the early stage of development preferentially synthesize activin rather than inhibin (Schwall et al., 1990; Yamoto et al., 1992) . However, analysis of the capacity of follicles at defined developmental stages to produce each assembled form of inhibin/activin dimer (activin A, AB, BB, inhibin A, inhibin B) and follistatin protein will ultimately be required to confirm that there is a functional excess of activin over inhibin and follistatin in follicles at the early stage of development.
Once granulosa cells have acquired functional FSH receptors, their proliferation and differentiation would be driven mainly by FSH (and LH at the preovulatory stage) but modulated by other extrinsic (for example insulin, growth hormone, leptin?) and locally produced factors having both stimulatory (for example oestradiol, IGF, activin) and inhibitory (for example TGF-α, IGFBPs, follistatin) actions (Greenwald and Roy, 1994; Webb et al., 1999) . A recent in vivo study in cattle aimed to define the biochemical characteristics of growing follicles that are destined to . Schematic diagram relating presumed changes in expression in granulosa cells of inhibin, activin and follistatin at different stages of follicle development to their putative regulatory functions at the intraovarian and peripheral level. Through its activin-binding capacity, follistatin can neutralize the biological activity of activin. Note that expression of inhibin A and follistatin is maintained in primate corpus luteum, but declines after ovulation in other species. Asterisks indicate roles restricted to primate species.
achieve dominance (Mihm et al., 2000) . Although no differences in follicular fluid concentrations of inhibin A, activin A or follistatin were evident, the study showed that by day 3 of the ovarian cycle the future dominant follicle had a lower intrafollicular concentration of IGFBP-4 and a higher concentration of oestradiol compared with cohort follicles of similar size. It is suggested that reduced intrafollicular IGFBP-4 makes more 'free' IGF available to amplify FSH responsiveness, and thus confers a selective advantage on this follicle. Studies in vitro in a range of species support a role for activin in the regulation of granulosa cell steroidogenesis, although the nature of this involvement appears to vary with the stage of follicular development. Studies involving non-luteinized granulosa cells from both immature and preovulatory marmoset follicles showed that activin can enhance basal and gonadotrophin-stimulated P450arom activity (Hillier and Miro, 1993) . This finding is consistent with other studies on rat and bovine granulosa cells showing that activin can enhance P450arom activity and oestradiol production while inhibiting progesterone secretion (Hutchinson et al., 1987; Miro et al., 1991; Shukovski et al., 1991) . These findings indicate that intrafollicular activin may have a role in delaying the onset of atresia and luteinization. Studies on cells from more developmentally advanced follicles (human granulosa lutein cells) revealed that activin has an anti-steroidogenic action, inhibiting basal and gonadotrophin-stimulated P450scc expression, progesterone secretion, P450arom activity and oestradiol production (Cataldo et al., 1994; Eramaa et al., 1995) . Follistatin reverses the effect of activin on progesterone secretion by human granulosa lutein cells (Cataldo et al., 1994) , whereas it has no effect in the absence of activin. Studies in rats have shown that follistatin can also suppress P450arom activity and inhibin production and increase progesterone secretion (Xiao et al., 1992) . These observations imply a role for follistatin in promoting follicle atresia (associated with decreased oestradiol and inhibin production and increased progesterone) or luteinization, depending on the developmental stage reached. The finding that transgenic mice overexpressing follistatin show arrested follicle development in vivo (Guo et al., 1998 ) is broadly consistent with the above evidence obtained in vitro.
Evidence for an autocrine role of inhibin in modulating granulosa cell steroidogenesis is more controversial. An early indication that inhibin can suppress FSH-induced P450arom activity in cultured rat granulosa cells (Ying et al., 1986) was not substantiated by later studies in rats (Hutchinson et al., 1987; Sugino et al., 1988) and humans (Rabinovici et al., 1994) . However, Miro and Hillier (1992) noted a small inhibin-induced decline in FSH-induced P450arom activity in marmoset granulosa cells obtained from immature follicles. Infusion of inhibin into the ovarian artery of ewes bearing an autotransplanted ovary reduced ovarian output of both androstenedione and oestradiol (Campbell and Scaramuzzi, 1996) . However, this finding is difficult to interpret since plasma FSH concentrations were also suppressed, raising the possibility of a pituitarymediated rather than direct ovarian action of the infused inhibin.
Granulosa cells express much more inhibin α subunit than βA/βB subunits (Ying et al., 1988; Knight, 1996) and several forms of monomeric inhibin α subunit have been identified in follicular fluid; these include full-length α precursor and a number of post-translational cleavage products including pro-αC, αC and αN. None of the free α forms isolated so far possesses classical inhibin-like bioactivity (that is the ability to suppress pituitary FSH secretion), but one study indicates that the full-length α precursor can compete with FSH for binding to its receptor and so attenuate the action of FSH on granulosa cells (Schneyer et al., 1991) . Thus, the intrafollicular concentration of free inhibin α subunit precursor could be another factor in determining how FSH responsive a particular follicle is. Further support for an intrafollicular role of inhibin α subunit comes from a study in which sheep were actively immunized against the αC region of the α subunit precursor (Tannetta et al., 1998) . Immunized sheep showed enhanced follicle development even though plasma gonadotrophin concentrations were similar to those in control sheep. Moreover, follicular concentrations of activin A, but not follistatin, were much higher in immunized sheep, consistent with the notion that activin upregulates granulosa cell responsiveness to FSH. This observation is reminiscent of the aforementioned finding (Matzuk et al., 1992 ) that inhibin α 'knockout' mice show raised activin concentrations and uncontrolled granulosa cell proliferation.
Another post-translational product of the α subunit precursor, termed the αN fragment, may have a local intrafollicular role to facilitate ovulation. Active immunization of ewes against αN had no detectable effect on reproductive hormones in the circulation but reduced litter size and disrupted ovulation as indicated by a reduced number of eggs in the oviducts and a greater incidence of luteinized or unruptured follicles and corpora lutea (Findlay et al., 1994) . It was subsequently shown that the lowered fertility of αN immunized ewes was associated with restricted tissue remodelling and reduced matrix metalloproteinase 2 activity in follicular fluid at the time of expected ovulation (Russell et al., 1995) .
Paracrine effects on theca cells
A characteristic feature of a dominant preovulatory follicle is its capacity to synthesize and secrete much greater amounts of oestrogen than its subordinates, which requires a high P450arom activity in granulosa cells and an adequate supply of P450arom substrate (androgen). In most species, granulosa cells lack P450c17 and are thus unable to synthesize their own androgen; they are therefore dependent on androgens synthesized by the surrounding theca cells. Studies in vitro on human (Hillier, 1991), rat (Hsueh et al., 1987) and bovine (Wrathall and Knight, 1995) theca cells have shown that inhibin A (a product of gonadotrophin-responsive oestrogen-active granulosa cells) can enhance LH-induced androgen production. Incubation of whole rat follicles (Smyth et al., 1993) with neutralizing antibodies to inhibin reduced androgen secretion, consistent with a positive action of endogenous inhibin on thecal androgen production. This action of inhibin could be an important intrafollicular positive feedback mechanism for ensuring that the preovulatory follicle obtains sufficient substrate to keep pace with increasing oestrogen synthesis.
Treatment of human, rat and bovine theca cells with activin reduces LH-induced androgen production and opposes the action of inhibin (Hsueh et al., 1987; Hillier, 1991; Wrathall and Knight, 1995) . In bovine theca cells, oestradiol upregulates thecal androgen production (Wrathall and Knight, 1995) , and this effect was also reduced by activin. Moreover, the inhibitory effects of activin on both LH-and oestradiol-induced androgen secretion were reversed by follistatin, consistent with its role as an activin-binding protein. Collectively, the findings from studies in vitro indicate that granulosa cell-derived inhibins and activins have mutually opposing paracrine actions to modulate thecal androgen synthesis. The effect of activin is, in turn, subject to regulation by follistatin produced locally.
Hillier (1991) proposed that in immature follicles, which synthesize very little oestrogen, thecal androgen synthesis is also low due to a relative excess of activin over inhibin and follistatin (that is, high 'activin tone', low 'inhibin tone'). However, as a dominant follicle approaches preovulatory status, increasing expression of inhibin and follistatin in granulosa cells, possibly accompanied by decreasing expression of activin (that is, low 'activin tone', high 'inhibin tone') upregulate thecal androgen secretion and thereby ensure that the granulosa cells receive an adequate supply of P450arom substrate to match the increasing demand for oestradiol synthesis (Fig. 4) . This hypothesis is supported by histological evidence of developmental changes in expression of inhibin/activin subunit and follistatin during folliculogenesis and by observed changes in intrafollicular concentrations of inhibins and activin A during follicular development (Magoffin and Jakimiuk, 1998). The latter authors showed that concentrations of activin A in follicular fluid were similar in human follicles ranging from 5 to 20 mm in diameter, whereas inhibin A and inhibin B concentrations increased markedly with follicle size. Unfortunately, intrafollicular follistatin concentrations were not measured by Magoffin and Jakimiuk (1998), so it was not possible to assess the relative amount of 'free' (presumably bioavailable) activin present at different stages.
Paracrine effects on the oocyte
As in the early stages of follicle development, it is evident that factors secreted by the oocyte continue to influence the surrounding somatic cells as follicle maturation proceeds.
Conversely, factors produced by somatic cells contribute to the ordered cytoplasmic and nuclear maturation of the oocyte and to the maintenance of 'meiotic arrest' until a preovulatory LH surge or follicle atresia ensues, or the oocyte is removed from its follicular environment for in vitro maturation (Greenwald and Roy, 1994; Eppig, 1996) .
Cumulus granulosa cells express high levels of inhibin/ activin α, βA, βB subunit and follistatin mRNA and protein (Roberts et al., 1993; Sidis et al., 1998; see Fig. 5a ) and oocytes express activin receptors (Cameron et al., 1994; Sidis et al., 1998) . These observations reinforce evidence from functional in vitro studies in several species that cumulus-derived activins affect nuclear and cytoplasmic maturation of oocytes. For instance, activin accelerates in vitro meiotic maturation of oocytes in monkeys (Alak et al., Late follicular phase. Granulosa cells of the preovulatory follicle respond to stimulation by FSH and LH with increased production of inhibin, paralleling the preovulatory increase in P450arom activity. Inhibin acts locally to promote LH-stimulated androgen synthesis by theca interna. As inhibin production increases (possibly in association with reduced production of activin and increased production of follistatin), a positive feedback loop is created through which thecal androgen synthesis is amplified to sustain oestrogen synthesis in the granulosa cell layer. (Adapted from Hillier, 1991.) 1996), rats (Sadatsuki et al., 1993) and humans (Alak et al., 1998) , an effect that was inhibited by follistatin. Exposure of denuded or cumulus-enclosed bovine oocytes to activin-A did not affect cleavage rate after IVF but increased their developmental competence to form blastocysts (Silva and Knight, 1998) . Conversely, follistatin reduced oocyte developmental competence and neutralized the effect of both endogenous and exogenous activin, consistent with its functional role as an activin-binding protein (Fig. 5b) . Evidence implicating inhibin as a potential modulator of oocyte maturation is less consistent, although it has been reported that inhibin can suppress the spontaneous maturation division of cumulus-enclosed and denuded oocytes from immature rats (O et al., 1989) . However, in conflict with other reports, activin had no effect in this study. In a recent study on cumulus-enclosed bovine oocytes (Silva et al., 1999) , free inhibin α subunit (pro-αC), but not inhibin A, was shown to reduce oocyte developmental competence. Moreover, addition of antibodies against α subunit enhanced oocyte developmental competence, an observation consistent with an inhibitory role of free inhibin α subunit, which is known to be produced in large amounts by cumulus cells. Irrespective of their physiological relevance to normal oocyte maturation in vivo, these observations indicate ways of improving the outcome of assisted reproduction techniques that involve manipulation of oocytes in vitro.
Autocrine-paracrine actions in the corpus luteum Expression of inhibin/activin subunits and follistatin in granulosa cells is downregulated after the LH surge and is low in the corpus luteum of most species examined. However, in primates, with the exception of βB subunit, the level of expression is maintained after ovulation (Yamoto et al., 1991; Roberts et al., 1993) . The corpus luteum becomes a significant source of inhibin A in particular and circulating concentrations peak in the mid-luteal phase of the human cycle (Muttukrishna et al., 1994) . These observations point to potential autocrine-paracrine actions of inhibin-related molecules in the regulation of luteal function in primates.
A role for endogenous inhibin (or its free α subunit) in promoting luteal progesterone production is indicated by the finding that addition of α inhibin antibody to marmoset luteal cells reduced hCG-induced progesterone secretion (Webley et al., 1994) . In contrast, activin has been shown to promote proliferation of cultured human granulosa lutein cells and decrease basal and hCG-induced progesterone secretion (Rabinovici et al., 1990; Di Simone et al., 1994) ; the latter response is reversed by follistatin (Cataldo et al., 1994) . Activin also suppresses progesterone secretion by cultured monkey luteal cells (Brannian et al., 1992) . Given that expression of follistatin is upregulated by hCG in granulosa lutein cells (Tuuri et al., 1994) , follistatin could be an important component of the gonadotrophin-dependent luteal support mechanism.
Conclusions
As discussed in this review, there is a wealth of evidence to support the view that inhibins, activins and follistatin function as intraovarian regulatory molecules involved in follicle cell proliferation, steroidogenesis, oocyte (b) Follistatin reduces blastocyst yield from cumulus-enclosed oocytes (COCs) to a value similar to that observed with cumulusfree (denuded) oocytes. Activin enhances blastocyst yield from cumulus-free oocytes to a value similar to that for cumulusenclosed oocytes. The effect of activin was blocked by follistatin.
(Data re-plotted from Silva and Knight, 1998.) maturation and corpus luteum function (see Fig. 6 for summary). However, it cannot be overemphasized that nearly all of this evidence has accrued from in vitro experiments on isolated cells and tissues. A key challenge now is to devise appropriate in vivo models to verify that these putative roles do indeed have physiological relevance in whole animals. The creation of transgenic mouse mutants lacking functional copies of the genes encoding inhibin/ activin α, βA, βB subunits, activin receptor subtypes and follistatin (for a review see Nishimori and Matzuk, 1996) has undoubtedly yielded major insights into the functional roles of these peptides, particularly in early mammalian development. However, this approach is not ideally suited to the in vivo analysis of gene function in particular organ systems at later developmental stages (for example cyclic ovarian function in an adult mammal); the challenge remains to develop improved whole animal experimental models for this purpose. (α43) N (1991) Cyclic changes in follistatin messenger ribonucleic acid and its protein in the rat ovary during the oestrous cycle Endocrinology 129 603-611 *Nishimori K and Matzuk MM (1996) Characterization of inhibin/activin subunit, activin receptor, and
